Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
JAMA ; 329(5): 421-422, 2023 02 07.
Artigo em Inglês | MEDLINE | ID: mdl-36656598

RESUMO

This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.


Assuntos
Antituberculosos , Tuberculose Latente , Mycobacterium tuberculosis , Humanos , Antituberculosos/uso terapêutico , Tuberculose Latente/tratamento farmacológico
2.
J Prim Care Community Health ; 13: 21501319221119942, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36000470

RESUMO

INTRODUCTION/OBJECTIVES: In the US, reactivation of latent tuberculosis infection (LTBI) accounts for 80% of new cases. In 2016, the US Preventive Services Task Force provided a new recommendation that primary care providers (PCPs) should conduct LTBI screening, whereas in the past, LTBI cases were evaluated and treated by specialty providers. This shift in care revealed knowledge gaps surrounding LTBI treatment among PCPs. This study assessed changes in PCPs' confidence for performing key aspects of LTBI care before and after participation in an LTBI Extension for Community Healthcare Outcomes (ECHO) course. METHODS: The ECHO Model™ is an evidence-based telementoring intervention. Participants were primary care team members from clinics throughout Massachusetts who voluntarily enrolled in the ECHO course. In this mixed-methods evaluation, primary outcomes were PCP self-reported confidence changes by pre- and post-course surveys and post-course semi-structured interviews. RESULTS: Twenty PCPs (43% of registered PCPs) attended at least 3 of the 6 sessions and 24 PCPs (31% of registered PCPs) completed at least one survey. Confidence increased in selecting a test (P = .004), interpreting tuberculosis infection test results (P = .03), and selecting a treatment regimen (P = .004). Qualitative interviews with 3 PCPs revealed practice changes including switching to interferon gamma release assays for testing and using rifampin for treatment. CONCLUSIONS: Use of the ECHO model to train PCPs in LTBI management is feasible and efficacious. For continuing medical education, ECHO courses can be leveraged to reduce health disparities in settings where PCPs' lack of familiarity about a treatment topic contributes to poor health outcomes.


Assuntos
Tuberculose Latente , Educação Médica Continuada , Humanos , Tuberculose Latente/diagnóstico por imagem , Tuberculose Latente/tratamento farmacológico , Programas de Rastreamento , Atenção Primária à Saúde , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA